Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and
operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity
& Administrative expenses increased by Baht 23.54 million or 13.02 % due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 3. Finance costs increased by Baht 13.17
increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling
valuable and useful comments from various stakeholders including governmental and private sectors, civil society, academic sector and international organizations. Most of the feedbacks agree with the
mechanism and be able to raise fund in capital market, while investors can find out information about the qualifications of potential SMEs and Startups that would be valuable choices for investment. In
these activities has led to further sharing of valuable information and knowledge to the public on a wider scale, reaching a diverse range of target groups, from the youth and students to first jobbers
these activities has led to further sharing of valuable information and knowledge to the public on a wider scale, reaching a diverse range of target groups, from the youth and students to first jobbers
expanding health care service providers including check-up and occupational health for general clients aimed to enhance the Company’s sustainability growth which involves the next step of expanding scope of
was in accordance with company’s continually expanding strategy and well management in sales and marketing function. The company; therefore, can gain more market share. 2. Selling and Administrative